A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities

被引:27
|
作者
Bera, Hriday [1 ,2 ]
Tan, Bee Jen [2 ]
Sun, Lingyi [2 ]
Dolzhenko, Anton V. [2 ,3 ]
Chui, Wai-Keung [2 ]
Chiu, Gigi Nagar Chee [2 ]
机构
[1] Gokaraju Rangaraju Coll Pharm, Hyderabad 500090, Andhra Pradesh, India
[2] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore
[3] Monash Univ, Sch Pharm, Bandar Sunway 46150, Selangor, Malaysia
基金
英国医学研究理事会;
关键词
1,2,4-Triazolo[1,5-a][1,3,5]triazine; Thymidine phosphorylase inhibitors; SAR; Mixed-type inhibition; Breast cancer; Anti-angiogenesis; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; NUCLEOSIDE DERIVATIVES; BREAST-CARCINOMA; INHIBITORS; 3(5)-AMINO-1,2,4-TRIAZOLES; EXPRESSION; CANCER;
D O I
10.1016/j.ejmech.2013.06.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thirty-three 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues were designed and synthesized which contained different substituents at meta- and/or para-positions of 2-phenyl or 2-benzyl ring attached to the fused ring structure. The preliminary pharmacological evaluation demonstrated that the 5-thioxo analogues of 1,2,4-triazolo[1,5-a][1,3,5]triazine exhibited a varying degree of inhibitory activity towards thymidine phosphorylase, comparable or better than reference compound, 7-Deazaxanthine (7-DX, 2) (IC50 value = 42.63 mu M). Moreover, compounds 5q and 6i displayed a mixed-type of inhibitory mechanism in the presence of variable concentrations of thymidine (dThd). In addition, selected compounds were found to have a noticeable inhibitory effect on the expression of angiogenesis markers, including VEGF and MMP-9 in MDA-MB-231 breast cancer cells. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 33 条